Octagon Capital Advisors »

Pharvaris N V shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 621k 18.52

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals (APLS)
Verona Pharma Sponsored Ads (VRNA)
Structure Therapeutics Sponsored Ads (GPCR)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Arrivent Biopharma (AVBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Nuvation Bio Com Cl A (NUVB)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Ocular Therapeutix (OCUL)
Miragen Therapeutics (VRDN)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Cogent Biosciences (COGT)
Bridgebio Pharma (BBIO)

View all positions for Octagon Capital Advisors

Top funds holding Pharvaris N V

General Atlantic
Foresite Capital Management IV
venBio Partners
Viking Global Investors
VR Adviser
Bain Capital Life Sciences Investors
Deerfield Management Company
Commodore Capital
Novo A/S
Cormorant Asset Management
EcoR1 Capital
5AM Venture Management
Rock Springs Capital Management
Octagon Capital Advisors
Sofinnova Ventures

View all funds holding Pharvaris N V